Human nasal epithelial cell culture system: evaluation of response to human interferons
- PMID: 193789
- PMCID: PMC420977
- DOI: 10.1128/iai.16.2.480-485.1977
Human nasal epithelial cell culture system: evaluation of response to human interferons
Abstract
This report describes the response of human nasal epithelial cells to exogenously applied human interferon (IF). To measure the response, a system developed to study human nasal epithelial cells in vitro was used. Nasal epithelial cells responded equally to both leukocyte and fibroblast IF, with development of resistance to virus replication that was time and dose dependent. Cells required contact with 1,000 U of IF (400 69/19 reference units) for 4 h to produce consistently a significant reduction in virus yield. This in vitro cell cultured system may be useful in predicting the in vivo response of human IF in respiratory viral infections.
Similar articles
-
Antiviral activity of intranasally applied human leukocyte interferon.Antimicrob Agents Chemother. 1978 Oct;14(4):596-600. doi: 10.1128/AAC.14.4.596. Antimicrob Agents Chemother. 1978. PMID: 214028 Free PMC article.
-
Rapid onset of the interferon-induced antiviral state in human nasal epithelial and foreskin fibroblast cells.Proc Soc Exp Biol Med. 1980 Jun;164(2):146-52. doi: 10.3181/00379727-164-40838. Proc Soc Exp Biol Med. 1980. PMID: 6156464 No abstract available.
-
Effect of human nasal secretions on the antiviral activity of human fibroblast and leukocyte interferon.Proc Soc Exp Biol Med. 1976 Sep;152(4):598-602. doi: 10.3181/00379727-152-39448. Proc Soc Exp Biol Med. 1976. PMID: 184472
-
Initial interaction of human fibroblast and leukocyte interferons with FS-4 fibroblasts.J Gen Virol. 1979 Jul;44(1):161-8. doi: 10.1099/0022-1317-44-1-161. J Gen Virol. 1979. PMID: 227987
-
Antibody neutralization studies of the antiviral activities of human leukocyte interferon on different cells.Arch Virol. 1980;65(3-4):229-36. doi: 10.1007/BF01314539. Arch Virol. 1980. PMID: 6158304
Cited by
-
Purified interferon as protection against rhinovirus infection.Br Med J (Clin Res Ed). 1982 Jun 19;284(6332):1822-5. doi: 10.1136/bmj.284.6332.1822. Br Med J (Clin Res Ed). 1982. PMID: 6177374 Free PMC article. Clinical Trial.
-
Pulmonary deposition and clearance of aerosolized interferon.Antimicrob Agents Chemother. 1984 Jun;25(6):729-34. doi: 10.1128/AAC.25.6.729. Antimicrob Agents Chemother. 1984. PMID: 6742817 Free PMC article.
-
Cell cytotoxicity due to specific influenza antibody production in vitro after recent influenza antigen stimulation.Proc Natl Acad Sci U S A. 1979 Sep;76(9):4622-6. doi: 10.1073/pnas.76.9.4622. Proc Natl Acad Sci U S A. 1979. PMID: 291990 Free PMC article.
-
Antiviral activity of intranasally applied human leukocyte interferon.Antimicrob Agents Chemother. 1978 Oct;14(4):596-600. doi: 10.1128/AAC.14.4.596. Antimicrob Agents Chemother. 1978. PMID: 214028 Free PMC article.
-
Failure of human fibroblast interferon to protect against rhinovirus infection.Arch Virol. 1980;65(2):135-9. doi: 10.1007/BF01317324. Arch Virol. 1980. PMID: 6158933 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous